Biosante Pharmaceuticals shares owned by Vanguard Group
Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Biosante Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Biosante Pharmaceuticals held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Biosante Pharmaceuticals by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $92M | 1.4M | 63.68 |
| 2024-03-31 | $90M | 1.3M | 69.13 |
| 2023-12-31 | $71M | 1.3M | 55.14 |
| 2023-09-30 | $66M | 1.1M | 58.06 |
| 2023-06-30 | $58M | 1.1M | 53.83 |
| 2023-03-31 | $33M | 834k | 39.72 |
| 2022-12-31 | $33M | 813k | 40.23 |
| 2022-06-30 | $24M | 814k | 29.67 |
| 2022-03-31 | $22M | 775k | 28.11 |
| 2021-09-30 | $21M | 645k | 32.82 |
| 2021-06-30 | $22M | 619k | 35.01 |
| 2021-03-31 | $24M | 659k | 36.15 |
| 2020-12-31 | $18M | 603k | 29.01 |
| 2020-09-30 | $16M | 568k | 28.21 |
| 2020-06-30 | $18M | 549k | 32.32 |
| 2020-03-31 | $24M | 591k | 40.74 |
| 2019-12-31 | $36M | 576k | 61.67 |
| 2019-09-30 | $43M | 586k | 73.33 |
| 2019-03-31 | $39M | 552k | 70.55 |
| 2018-12-31 | $24M | 528k | 45.00 |
| 2018-09-30 | $30M | 523k | 56.52 |
| 2018-06-30 | $34M | 515k | 66.79 |
| 2018-03-31 | $29M | 494k | 58.24 |
| 2017-12-31 | $31M | 481k | 64.42 |
| 2017-09-30 | $25M | 475k | 51.67 |
| 2017-06-30 | $22M | 477k | 46.82 |
| 2017-03-31 | $22M | 441k | 49.49 |
| 2016-12-31 | $25M | 417k | 60.00 |
| 2016-09-30 | $26M | 389k | 66.36 |
| 2016-06-30 | $22M | 386k | 55.79 |
| 2015-12-31 | $16M | 361k | 45.15 |
| 2015-09-30 | $14M | 341k | 40.00 |
| 2015-06-30 | $21M | 343k | 62.09 |
| 2015-03-31 | $19M | 297k | 62.51 |
| 2014-12-31 | $13M | 226k | 56.40 |
| 2014-09-30 | $6.3M | 224k | 28.28 |
| 2014-06-30 | $7.2M | 210k | 34.46 |
| 2014-03-31 | $6.2M | 199k | 31.37 |
| 2013-12-31 | $2.2M | 108k | 20.08 |
| 2013-09-30 | $875k | 87k | 10.04 |